Answer
Subgam (human normal immunoglobulin) is indicated as subcutaneous replacement therapy in adults, children and adolescents (0–18 years) with chronic lymphocytic leukaemia who have hypogammaglobulinaemia and recurrent bacterial infections when prophylactic antibiotics have failed or are contraindicated.
Sources for this answer
- Subgam, Human normal immunoglobulin solutionBio Products Laboratory Limited · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked